Menlo Park, CA, United States of America

Tracy Saxton

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tracy Saxton - Innovator in Pyrimidine Compounds

Introduction

Tracy Saxton is a notable inventor based in Menlo Park, California. She has made significant contributions to the field of medicinal chemistry, particularly through her work on pyrimidine compounds. With a focus on their applications in pharmaceuticals, her innovations have the potential to impact various therapeutic areas.

Latest Patents

Tracy Saxton holds a patent for "Pyrimidine compounds, compositions, and medicinal applications thereof." This patent encompasses a class of pyrimidine compounds, including their stereoisomers, tautomers, and pharmaceutically acceptable salts. The disclosure also details a process for preparing these compounds, along with pharmaceutical compositions that incorporate them and their medicinal applications.

Career Highlights

Tracy is currently employed at Blueprint Medicines Corporation, where she continues to advance her research in medicinal applications. Her work is characterized by a commitment to innovation and the development of new therapeutic solutions.

Collaborations

Throughout her career, Tracy has collaborated with talented individuals such as Gurulingappa Hallur and Naveena Madhyastha. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Tracy Saxton's contributions to the field of pyrimidine compounds exemplify her dedication to innovation in medicinal chemistry. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…